clarithromycin has been researched along with fluticasone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ameredes, BT; Bleecker, E; Boushey, HA; Calhoun, WJ; Castro, M; Cherniack, RM; Chinchilli, VM; Chu, HW; Craig, TJ; Denlinger, L; DiMango, EA; Fahy, JV; Icitovic, N; Israel, E; Jarjour, N; King, TS; Kraft, M; Lazarus, SC; Lemanske, RF; Martin, RJ; Peters, SP; Ramsdell, J; Sorkness, CA; Sutherland, ER; Szefler, SJ; Walter, MJ; Wasserman, SI; Wechsler, ME | 1 |
| Cao, PP; Liao, B; Liu, JX; Liu, Z; Long, XB; Ma, J; Ning, Q; Wang, H; Zeng, M | 1 |
2 trial(s) available for clarithromycin and fluticasone
| Article | Year |
|---|---|
A trial of clarithromycin for the treatment of suboptimally controlled asthma.
Topics: Adult; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Asthma; Chlamydophila pneumoniae; Clarithromycin; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Polymerase Chain Reaction; Surveys and Questionnaires; Treatment Outcome | 2010 |
Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial.
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Fluticasone; Humans; Nasal Polyps; Prospective Studies; Rhinitis; Single-Blind Method; Sinusitis | 2019 |
2 other study(ies) available for clarithromycin and fluticasone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |